Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD
SZSE:300534.SZ
9.22 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 291.889 | 254.914 | 267.744 | 220.834 | 295.149 | 296.323 | 189.751 | 73.114 | 95.123 | 55.259 | 121.126 | 59.004 | 58.53 | 49.154 | 86.96 | 72.448 | 47.665 | 47.826 | 77.237 | 51.308 | 52.365 | 58.093 | 49.813 | 42.39 | 53.092 | 57.871 | 76.385 | 62.834 | 72.521 | 57.847 | 80.832 | 65.472 | 77.212 | 46.165 | 89.63 | 58.772 |
| Cost of Revenue
| 73.526 | 67.036 | 118.488 | 73.442 | 91.849 | 102.451 | 116.073 | 45.261 | 54.546 | 33.643 | 77.454 | 40.481 | 40.879 | 36.607 | 52.238 | 47.806 | 37.329 | 34.426 | 48.779 | 30.977 | 34.199 | 34.583 | 24.931 | 22.758 | 33.328 | 35.748 | 50.24 | 41.865 | 48.908 | 40.451 | 51.951 | 41.829 | 48.5 | 29.635 | 56.421 | 34.518 |
| Gross Profit
| 218.363 | 187.878 | 149.256 | 147.392 | 203.3 | 193.872 | 73.678 | 27.853 | 40.577 | 21.616 | 43.672 | 18.522 | 17.651 | 12.547 | 34.722 | 24.643 | 10.336 | 13.399 | 28.458 | 20.33 | 18.166 | 23.51 | 24.882 | 19.632 | 19.764 | 22.123 | 26.145 | 20.969 | 23.613 | 17.397 | 28.881 | 23.643 | 28.711 | 16.53 | 33.21 | 24.254 |
| Gross Profit Ratio
| 0.748 | 0.737 | 0.557 | 0.667 | 0.689 | 0.654 | 0.388 | 0.381 | 0.427 | 0.391 | 0.361 | 0.314 | 0.302 | 0.255 | 0.399 | 0.34 | 0.217 | 0.28 | 0.368 | 0.396 | 0.347 | 0.405 | 0.5 | 0.463 | 0.372 | 0.382 | 0.342 | 0.334 | 0.326 | 0.301 | 0.357 | 0.361 | 0.372 | 0.358 | 0.371 | 0.413 |
| Reseach & Development Expenses
| 6.014 | 3.984 | 9.522 | 6.314 | 8.619 | 5.718 | 4.09 | 2.141 | 1.643 | 1.5 | 2.494 | 1.649 | 1.387 | 1.168 | 1.874 | 1.149 | 1.398 | 1.553 | 3.691 | 1.197 | 1.294 | 1.23 | 3.343 | 1.356 | 1.006 | 1.027 | 2.094 | 1.854 | 2.188 | 0 | 6.356 | 0 | 3.908 | 0 | 10.19 | 0 |
| General & Administrative Expenses
| -3.631 | 10.636 | -16.292 | 25.322 | -5.153 | 12.73 | -8.161 | 14.597 | -2.899 | 5.291 | -10.49 | 13.127 | -3.258 | 5.347 | -11.624 | 4.204 | -2.847 | 4.96 | -11.97 | 5.572 | -3.151 | 4.793 | -8.937 | 4.079 | -3.473 | 5.126 | -12.412 | 6.269 | -3.066 | 4.98 | -10.066 | 3.935 | -3.004 | 3.732 | -9.842 | 2.65 |
| Selling & Marketing Expenses
| 184.113 | 135.089 | 103.926 | 110.453 | 155.029 | 138.619 | 33.492 | 15.347 | 28.843 | 14.022 | 24.791 | 21.135 | 15.385 | 5.877 | 15.964 | 17.779 | 13.956 | 4.989 | 11.623 | 14.708 | 10.096 | 9.184 | 15.326 | 14.754 | 8.361 | 8.822 | 15.471 | 14.91 | 11.089 | 5.097 | 12.025 | 6.543 | 6.07 | 1.116 | 4.7 | 1.919 |
| SG&A
| 193.643 | 145.725 | 87.634 | 135.775 | 149.876 | 151.349 | 25.331 | 29.944 | 25.944 | 19.313 | 14.301 | 34.262 | 12.127 | 11.224 | 4.34 | 21.983 | 11.109 | 9.949 | -0.347 | 20.28 | 6.945 | 13.977 | 6.389 | 18.833 | 4.887 | 13.948 | 3.059 | 21.179 | 8.024 | 10.076 | 1.959 | 10.478 | 3.066 | 4.847 | -5.141 | 4.569 |
| Other Expenses
| -2.289 | 0.051 | 2.142 | -0.03 | -0.27 | -0.023 | 5.325 | 0.328 | -0.186 | 0 | 0.472 | -0.114 | 4.323 | -0.046 | 1.711 | 0.079 | -0.21 | -0.007 | 0.827 | -0.327 | 0.001 | -0 | -0.044 | -0.001 | 0.036 | -0 | 0.021 | 0.012 | 1.683 | 2.377 | 2.405 | 1.318 | 0.601 | 0.298 | 0.637 | 0.258 |
| Operating Expenses
| 199.657 | 151.886 | 128.948 | 127.566 | 176.224 | 159.765 | 51.548 | 24.306 | 36.81 | 21.166 | 37.35 | 26.699 | 21.187 | 12.302 | 22.919 | 22.843 | 20.763 | 11.717 | 14.266 | 21.766 | 15.236 | 15.885 | 23.287 | 19.165 | 14.369 | 14.644 | 23.467 | 21.303 | 17.509 | 11.252 | 19.612 | 11.11 | 11.661 | 5.46 | 12.598 | 5.311 |
| Operating Income
| 18.706 | 36.45 | 20.589 | 20.435 | 18.838 | 35.337 | 15.791 | 4.169 | 5.869 | 0.903 | 1.918 | -7.684 | -3.949 | 0.331 | 11.148 | 1.707 | -12.128 | 1.518 | 10.954 | -1.465 | 2.144 | 7.899 | 0.943 | 0.631 | 4.355 | 7.595 | 3.156 | -1.036 | 5.253 | 6.648 | 8.384 | 13.872 | 15.994 | 11.862 | 18.634 | 18.716 |
| Operating Income Ratio
| 0.064 | 0.143 | 0.077 | 0.093 | 0.064 | 0.119 | 0.083 | 0.057 | 0.062 | 0.016 | 0.016 | -0.13 | -0.067 | 0.007 | 0.128 | 0.024 | -0.254 | 0.032 | 0.142 | -0.029 | 0.041 | 0.136 | 0.019 | 0.015 | 0.082 | 0.131 | 0.041 | -0.016 | 0.072 | 0.115 | 0.104 | 0.212 | 0.207 | 0.257 | 0.208 | 0.318 |
| Total Other Income Expenses Net
| 0.378 | 0.509 | -10.124 | -0.03 | -0.27 | -0.023 | 5.325 | 0.328 | -0.186 | 0 | 0.472 | -0.114 | 4.323 | -0.046 | 1.711 | 0.079 | -0.21 | -0.007 | 0.827 | -0.327 | 0.001 | -0 | -0.044 | -0.001 | 0.036 | -0 | 0.021 | 0.012 | 1.683 | 2.377 | 2.405 | 1.318 | 0.601 | 0.298 | 0.637 | 0.258 |
| Income Before Tax
| 19.085 | 36.501 | 22.731 | 20.405 | 18.569 | 35.314 | 21.116 | 4.498 | 5.683 | 0.903 | 2.39 | -7.798 | 0.374 | 0.285 | 12.859 | 1.786 | -12.338 | 1.511 | 11.782 | -1.792 | 2.145 | 7.899 | 0.899 | 0.63 | 4.392 | 7.594 | 3.178 | -1.024 | 6.937 | 9.025 | 10.788 | 15.19 | 16.595 | 12.16 | 19.271 | 18.974 |
| Income Before Tax Ratio
| 0.065 | 0.143 | 0.085 | 0.092 | 0.063 | 0.119 | 0.111 | 0.062 | 0.06 | 0.016 | 0.02 | -0.132 | 0.006 | 0.006 | 0.148 | 0.025 | -0.259 | 0.032 | 0.153 | -0.035 | 0.041 | 0.136 | 0.018 | 0.015 | 0.083 | 0.131 | 0.042 | -0.016 | 0.096 | 0.156 | 0.133 | 0.232 | 0.215 | 0.263 | 0.215 | 0.323 |
| Income Tax Expense
| 13.076 | 5.698 | 1.813 | 2.954 | 2.381 | 6.02 | -0.568 | 0.602 | 1.71 | 0.16 | 1.565 | 0.3 | -0.361 | 0.045 | -0.186 | 1.877 | -1.682 | 0.527 | 3.092 | -0.02 | 0.382 | 1.216 | -0.741 | 0.672 | 0.13 | 1.176 | -1.041 | -0 | 0.671 | 1.373 | 1.102 | 2.253 | 2.286 | 1.84 | 2.035 | 2.858 |
| Net Income
| -0.688 | 22.141 | 14.82 | 14.634 | 12.188 | 20.005 | 20.378 | 3.488 | 1.351 | 0.611 | -0.919 | -8.48 | 0.102 | 0.191 | 14.591 | -2.219 | -10.75 | 0.209 | 7.334 | -2.599 | 1.36 | 6.683 | 1.64 | -0.042 | 4.262 | 6.418 | 4.219 | -1.024 | 6.266 | 7.652 | 9.687 | 12.937 | 14.309 | 10.32 | 17.236 | 16.117 |
| Net Income Ratio
| -0.002 | 0.087 | 0.055 | 0.066 | 0.041 | 0.068 | 0.107 | 0.048 | 0.014 | 0.011 | -0.008 | -0.144 | 0.002 | 0.004 | 0.168 | -0.031 | -0.226 | 0.004 | 0.095 | -0.051 | 0.026 | 0.115 | 0.033 | -0.001 | 0.08 | 0.111 | 0.055 | -0.016 | 0.086 | 0.132 | 0.12 | 0.198 | 0.185 | 0.224 | 0.192 | 0.274 |
| EPS
| -0.002 | 0.073 | 0.049 | 0.048 | 0.04 | 0.066 | 0.067 | 0.012 | 0.004 | 0.002 | -0.003 | -0.028 | 0 | 0.001 | 0.047 | -0.007 | -0.035 | 0.001 | 0.024 | -0.009 | 0.005 | 0.022 | 0.005 | -0 | 0.014 | 0.021 | 0.014 | -0.003 | 0.021 | 0.025 | 0.032 | 0.057 | 0.063 | 0.045 | 0.076 | 0.071 |
| EPS Diluted
| -0.002 | 0.073 | 0.049 | 0.048 | 0.04 | 0.066 | 0.067 | 0.012 | 0.004 | 0.002 | -0.003 | -0.028 | 0 | 0.001 | 0.047 | -0.007 | -0.035 | 0.001 | 0.024 | -0.009 | 0.005 | 0.022 | 0.005 | -0 | 0.014 | 0.021 | 0.014 | -0.003 | 0.021 | 0.025 | 0.032 | 0.057 | 0.063 | 0.045 | 0.076 | 0.071 |
| EBITDA
| 26.762 | 37.41 | 24.091 | 21.491 | 19.652 | 36.006 | 31.364 | 1.177 | 6.137 | 0.449 | 7.274 | -7.886 | 0.257 | 0.937 | 13.852 | 2.388 | -11.703 | 1.83 | 15.184 | -1.721 | 2.93 | 7.625 | 1.324 | 0.467 | 5.394 | 7.479 | 1.912 | 0.535 | 9.817 | 6.145 | 16.466 | 12.309 | 18.369 | 11.07 | 22.871 | 19.328 |
| EBITDA Ratio
| 0.092 | 0.147 | 0.09 | 0.097 | 0.067 | 0.122 | 0.165 | 0.016 | 0.065 | 0.008 | 0.06 | -0.134 | 0.004 | 0.019 | 0.159 | 0.033 | -0.246 | 0.038 | 0.197 | -0.034 | 0.056 | 0.131 | 0.027 | 0.011 | 0.102 | 0.129 | 0.025 | 0.009 | 0.135 | 0.106 | 0.204 | 0.188 | 0.238 | 0.24 | 0.255 | 0.329 |